Podcasts about world antimicrobial awareness week

Resident GP and CEO of Proactive Health Solutions, Dr Fundile Nyati on concerns against the unnecessary use of antibiotics as it may lead to resistance, as we observe World Antimicrobial Awareness Week (18 –24 November), the Gauteng Department of Health has urged the public to avoid the misuse of antibiotics. See omnystudio.com/listener for privacy information.

Dubbed the superbug pandemic, antimicrobial resistance (AMR) has been recognised by the World Health Organization as one of the top 10 public health threats facing humanity. Effective antibiotics underpin modern medicine and yet, it takes just two to three years for new antimicrobial medicines to become ineffective against superbugs. Worryingly, the innovation pipeline for new antibiotics is stagnating. An estimated 10 million people globally will die each year by 2050 from infections that can be readily treated today. To mark this year's World Antimicrobial Awareness Week, MTPConnect and its Australian Antimicrobial Resistance Network (AAMRNet), has launched the second of its Fighting Superbugs reports, Fighting Superbugs: Ensuring Australia is Ready to Combat the Rise of Drug Resistant Infections, prepared in response to the Australian Parliament's report, The New Frontier – Delivering better health for all Australians. The independent report developed by Evohealth presents nine recommendations, urging immediate action to enhance the availability of new antibiotics and equip the Australian healthcare system to fight the superbug pandemic. Hosts Caroline Duell and MTPConnect's Andrew Bowskill co-chair of the AAMRNet discuss AMR with two of the reports' authors - Former Chair of the Pharmaceutical Benefits Advisory Committee Emeritus Professor Lloyd Sansom, a renowned pharmacy academic, policy advisor and researcher and Renae Beardmore, Founder and Managing Director of specialist health advisory firm Evohealth and former Chief Pharmacist for the ACT. You can find the report on MTPConnect's website.

Recent stats show Newfoundland and Labrador writes the most prescriptions of any province. Six years ago, Dr. Peter Daley, an infectious disease specialist at MUN, sounded the alarm about it. He said if something wasn't done to reduce the number of prescriptions, there would be disastrous consequences. This week is World Antimicrobial Awareness Week, and Dr. Daley gave us an update on what's been done since his warning.

Drug resistance is one of the most serious health threats facing humanity. Bacteria, fungi, viruses, and parasites are learning more and more to resist the medicines that are meant to kill them. These 'superbugs' can spread easily, increasing the risk of prolonged illness, or even death, from common infections. And the danger for cancer patients is particularly high. One of the reasons is the overuse and misuse of antimicrobial medicines. By 2050, Antimicrobial Resistance (AMR) could cause 10 million deaths per year and cost more than USD 100 trillion to public health - if no action is taken.On the occasion of World Antimicrobial Awareness Week from 18-23 November, Cary Adams, UICC's CEO speaks with Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance and former Chief Medical Officer for England.Cary Adams, UICC's CEO speaks with Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance and former Chief Medical Officer for England. Hosted on Acast. See acast.com/privacy for more information.

Right on the heels of the 2022 World Antimicrobial Awareness Week, this episode covers a broad overview of the key topics associated with antimicrobial resistance. Rose Doyle from BioPOD teamed up with Carys Redman-White from the new Edinburgh antimicrobial resistance podcast EdiAMR to chat to Dr Brian Wee about his work. We hear his thoughts on the best tools and tactics to combat the rise of antibiotic resistance as well as a deep dive into one decade-long research project about the spread of antibiotic resistance in Kenya. Art by Annis Newman, intro and editing by Severina Pociunaite.If you want to learn more about Brian's work on whole genome sequencing across Nairobi, check out his paper here: https://www.nature.com/articles/s41564-022-01079-y This episode is a collaboration between BioPOD and the University of Edinburgh's new antimicrobial resistance podcast, EdiAMR. If you're interested to find out more about AMR, follow @EdiAMR on twitter for updates! 

Diese Woche ist "World Antimicrobial Awareness Week" - weltweit wird auf die bedrohliche Zunahme von Resistenzen gegen Antibiotika aufmerksam gemacht. Daher rückt eine mögliche Alternative zu Antibiotika in den Fokus: Eine Therapie, die Bakterien mit Viren bekämpfen will. Von Anna Corves

It's World Antimicrobial Awareness Week and this year's theme is “Preventing Antimicrobial Resistance Together”. We chat to Bugworks, a clinical stage pharmaceutical company, headquartered in the US, with subsidiaries in India and Australia, currently developing novel antibacterials and immunotherapies.Bugworks' Co-founder and Chief Executive Officer, Dr Anand Anandkumar, joins the podcast from Bangalore, India to talk about the challenges of developing new antimicrobials, the boost from CARB-X accelerator that is keeping their lights on, and why push and pull incentives are vital for innovation. Dr Anandkumar reveals why the company chose Adelaide in South Australia as the site for the first-in-human Phase 1 clinical trial of one of two antibacterial agents in development. And we pose the question – does Australia need a CARB-X style accelerator to supercharge its efforts to curb AMR?Joining host Caroline Duell is Andrew Bowskill, MTPConnect's Director of Stakeholder Engagement for Queensland and co-chair of the Australian Antimicrobial Resistance Network (AAMRNet), established by MTPConnect as Australia's first multi-stakeholder expert group formed to address the impact of antimicrobial resistance (AMR) on human health. AAMRNet, in conjunction with CSIRO, recently released the ‘Antimicrobial Resistance (AMR) Impact Report: How big is Australia's AMR threat?, which reviews gaps in our data collection methods to find out how many people are dying from drug-resistant infections in Australia. 

Today on The Panel Wallace and panellists Anjum Rahman and Peter Dunne discuss antibiotic resistance on World Antimicrobial Awareness Week. Plus, they discuss the comments a visitor made about Aotearoa not having good freedom camping and the Snooker National Championships.

In this episode of The ASHE Podcast, Priya Nori is joined by guests, Bradley J. Langford, Kelly L. Matson, Khalid Eljaaly discuss World Antimicrobial Awareness Week and their recently published ASHE paper, “Ten ways to make the most of World Antimicrobial Awareness Week.” Learn more about our panelists efforts to improve awareness and understanding of AMR and find out what you can to do help improve AMR awareness in your community. Articles referenced in today's podcast are: https://quiz.tryinteract.com/#/59e68e3a8ecd1200126656e8 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/ten-ways-to-make-the-most-of-world-antimicrobial-awareness-week/2659CF3EC1C58AA3CE0A1B9C7F416545 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/antibiotic-prescribing-knowledge-a-brief-survey-of-providers-and-staff-at-an-ambulatory-cancer-center-during-antibiotic-awareness-week-2019/643A207747AA95A4E101B04AC05B09D1 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/assessing-baccalaureate-nursing-students-antibiotic-stewardship-knowledge-using-virtual-standardized-patient-simulations/938A0373CB12BF3F6E5C5C0207DCD8DB

The COVID-19 pandemic drove home an important lesson: that the smallest organisms can be the deadliest. Not only are they highly fatal, they are also incredibly adept at evading the antibiotics and antimicrobials that we have in our relatively pitiful arsenal of drugs. In conjunction with World Antimicrobial Awareness Week (18-24 November), Prof Stephen Baker, molecular microbiologist and Director of Research at the Department of Medicine, University of Cambridge, dials in to share his research on antimicrobial resistance, and how we can change the course of this global health threat. Image Credit: Shutterstock

Can you imagine a society where every individual and organization acts and works in a way to reduce the impact of antibiotic resistance? A society where everyone is aware of the problem and engaged in trying to resolve it? How would that look to you? For this year's World Antimicrobial Awareness Week we bring you the Antibiotic Smart Sweden initiative, a mission-oriented approach to system change, highlighting the importance of antibiotic resistance not just as a medical issue, but as a public health issue that is relevant to the whole society and sustainable development. Check out the show notes at www.uac.uu.se/the-amr-studio/episodex9/. Follow our updates on twitter on www.twitter.com/uac_uu with #theAMRstudio hashtag! Theme music by Henrik Niss: www.tinyurl.com/henriknissspotify.

In this special episode for World Antimicrobial Awareness Week, Martin talks to UKHSA subject experts about the ESPAUR Report (English Surveillance Programme for Antimicrobial Utilisation and Resistance) released earlier today. You can find out more on the report at the ESPAUR webinar on 23rd November and can register here to attend: https://www.eventbrite.co.uk/e/espaur-report-2021-to-2022-webinar-tickets-439575370767    The UK Health Security Agency (UKHSA) is responsible for protecting every member of every community from the impact of infectious diseases, chemical, biological, radiological and nuclear incidents and other health threats. UKHSA provides intellectual, scientific and operational leadership at national and local level, as well as on the global stage, to make the nation's health secure.  UKHSA leads the English surveillance programme for antimicrobial utilisation and resistance. ESPAUR publish a report annually which includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation, and awareness activities. It is published here during World Antimicrobial Awareness Week.     https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report  The national WAAW toolkit which includes a range of resources colleagues can use is available here https://www.gov.uk/government/publications/european-antibiotic-awareness-day-resources-toolkit-for-healthcare-professionals-in-england     

In this special episode for World Antimicrobial Awareness Week, Martin talks to UKHSA subject experts about the ESPAUR Report (English Surveillance Programme for Antimicrobial Utilisation and Resistance) released earlier today. You can find out more on the report at the ESPAUR webinar on 23rd November and can register here to attend: https://www.eventbrite.co.uk/e/espaur-report-2021-to-2022-webinar-tickets-439575370767    The UK Health Security Agency (UKHSA) is responsible for protecting every member of every community from the impact of infectious diseases, chemical, biological, radiological and nuclear incidents and other health threats. UKHSA provides intellectual, scientific and operational leadership at national and local level, as well as on the global stage, to make the nation's health secure.  UKHSA leads the English surveillance programme for antimicrobial utilisation and resistance. ESPAUR publish a report annually which includes national data on antimicrobial prescribing and resistance, antimicrobial stewardship implementation, and awareness activities. It is published here during World Antimicrobial Awareness Week.     https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report  The national WAAW toolkit which includes a range of resources colleagues can use is available here https://www.gov.uk/government/publications/european-antibiotic-awareness-day-resources-toolkit-for-healthcare-professionals-in-england     

We are currently in "World Antimicrobial Awareness Week". Tomorrow from noon to one pm, as part of MUN's Research Week, Eastern Health & Quality of Care Nfld and Labrador will be presenting a free webinar open to all called "The World is Running Out of Antibiotics." Dr. Peter Daley is one of the speakers.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week started with World Diabetes Day on 14 November and concluded with the start of World Antimicrobial Awareness Week, which aims to improve education and understanding of the growing issue of antimicrobial resistance. There were also exciting developments in the field of oncology, with researchers identifying potential new drug targets, new ways to predict treatments outcomes in the lab, and positive trial results for a new cell therapy.  

1:45 Labiotech.eu news4:02 PsychoGenics20:56 Destiny Pharma36:30 QureTech Bio54:41 AiCuris70:45 JLLThis week, we have three interviews on the theme of antimicrobial resistance (AMR), to mark World Antimicrobial Awareness Week. We spoke with Holger Zimmermann, CEO of anti-infectives company AiCuris; Neil Clark, CEO of Destiny Pharma, and Fredrik Almqvist, co-founder of QureTech Bio.We also have an interview with the chief scientific officer at PsychoGenics, Mark Varney. We also have our weekly contribution from global commercial real estate services company JLL, with Travis McCready. Next week, we will be moderating a webinar on the microbiome, hosted by our sister company IN-PART. You can register here.World Antimicrobial Awareness WeekAs a result of drug resistance, antibiotics and other antimicrobial medicines may become ineffective and infections become increasingly difficult or impossible to treat. A global action plan to tackle the growing problem of resistance to antibiotics and other antimicrobial medicines was endorsed at the 68th World Health Assembly in 2015. A key objective of the plan is to improve awareness and understanding of AMR through effective communication, education and training.World Antimicrobial Awareness Week is a global campaign to improve awareness and understanding of AMR. Emyria commences US preclinical program with PsychoGenicsEmyria Limited, a clinical stage biotech, is working with PsychoGenics, a specialist neuroscience preclinical drug discovery and contract research organization (CRO). Emyria and partner, the University of Western Australia, will start by screening five novel MDMA analogs from their proprietary library using PsychoGenics' advanced drug discovery platform, SmartCube. SmartCube employs computer vision and artificial intelligence (AI) to extract and analyze behavioral and physiological data from mice. These data can help predict the clinical effects of new drug compounds by comparing the novel drug's effects to reference drug libraries. The automated testing platform offers an effective approach to the discovery and development of the next generation of breakthrough treatments for neurological disorders and can significantly reduce the time and cost to reaching approved Investigational New Drug status. PsychoGenics and Emyria have agreed to work collaboratively (at their own costs) in the initial phase, before exploring drug discovery and commercialization partnership models. PsychoGenics's specialist drug screening platforms have been used in shared-risk partnerships with major pharmaceutical companies, including Sunovion and Roche, resulting in the discovery of several novel compounds now in clinical trials or advanced preclinical development. A successful partnership with Emyria could accelerate the development of Emyria's novel MDMA-inspired drug candidate library, built with the University of Western Australia, into new treatments for severe neuropsychiatric disorders. PsychoGenics has successfully identified novel treatment candidates for serious and complex neuropsychiatric disorders via its proprietary SmartCube platform as well as formed innovative partnerships with major Pharmaceutical companies.SponsorInterested in sponsoring one or more episodes of the podcast? Learn more here!Leave a review on Apple podcastsReviews are hugely important because they help new people discover this podcast. If you enjoyed listening to this episode, we would love to hear your feedback!Connect with us

Today marks the start of World Antimicrobial Awareness Week and while it's not the most catchy name, it's a topic hugely important for the health of humanity. MPI Deputy director-general Vincent Arbuckle talks to Jesse.

For this special episode the Apothecaries are joined by Professor Phil Howard ,OBE, to discuss Antimicrobial Resistance and what we can all do to tackle it. Phil is well placed to discuss this with us as the Antimicrobial Stewardship Lead for the North-East & Yorkshire region of England and the former President of the British Society of Antimicrobial Chemotherapy. World Antimicrobial Awareness Week (18-24th November) aims to increase awareness of global antimicrobial resistance and to encourage best practices for using antimicrobials responsibly among the general public, health workers and policy makers, to avoid the further emergence and spread of drug-resistant infections https://www.gov.uk/government/publications/european-antibiotic-awareness-day-resources-toolkit-for-healthcare-professionals-in-england/world-antimicrobial-awareness-week-waaw-and-european-antibiotic-awareness-day-eaad.We explore why prescribers might feel compelled to prescribe antibiotics in spite of the risks and what can be done to support prudent prescribing. We hear examples of good practice and about the resources that are out there to help people. Don't miss an exciting announcement about a future partnership between the Three Apothecaries and the British Society of Antimicrobial Chemotherapy! We discuss previous Health Secretary's admission that she had shared unused antibiotics with friends and family…As with all of our guests, Phil shares with us a Memorable Drug, a career anthem and book that has influenced his career. Expect an antimicrobial theme!Our micro-discussion focuses on the role of community pharmacy in supplying antibiotics and in particular the sore throat test and treat service that is in operation in Wales. An improvement in care or a risk to resistance? We discuss the latest research and give our verdict (https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkac358/6770011).The Royal Pharmaceutical Antibiotic Amnesty Toolkit can be found here; https://www.rpharms.com/resources/pharmacy-guides/antimicrobial-resistance-and-stewardship/antibiotic-amnesty.The Antibiotic Freakonomics podcasts mentioned can be found at https://freakonomics.com/podcast/cassandra-quave-thinks-the-way-antibiotics-are-developing-might-kill-us/https://freakonomics.com/podcast/doctors-know-they-prescribe-too-many-antibiotics-why-dont-they-stop/To get in touch follow us on Twitter @auralapothecary or email us at auralapothecarypod@gmail.com . Don't forget to rate us and comment wherever you have got this podcast from. You can listen to the Aural Apothecary musical playlist here; https://open.spotify.com/playlist/3OsWj4w8sxsvuwR9zMXgn5?si=tiHXrQI7QsGtSQwPyz1KBg You can view the Aural ApothecaryLibrary here; https://www.goodreads.com/review/list/31270100-paul-gimson?ref=nav_mybooks&shelf=the-aural-apothecaryPhil can be found on Twitter at @AntibioticLeedsPhil Howard BioPhilip Howard is the Antimicrobial Stewardship Lead for the North-East & Yorkshire region of England. He was a Consultant Pharmacist in Antimicrobials at the Leeds Teaching Hospitals NHS Trust until September 2021 and Honorary Visiting Professor at Leeds University. He is the former President of the British Society of Antimicrobial Chemotherapy. He was a member of the Dept of Health ARHAI Antimicrobial Stewardship Group that produced the original Start Smart then Focus Antimicrobial Stewardship Guidelines, and the HPA Primary Care Unit which helped produce the RCGP TARGET guidance on Antimicrobial Stewardship in Primary Care. He is a member of the UK Dept of Health advisory group on AMR & HCAI and the NICE common infections guidelines group, NICE living CoVID guideline group and the NICE new models of antimicrobial funding committee. His research interests include Antimicrobial Stewardship and antibiotic shortages. He led the first global hospital Antimicrobial Stewardship survey. He has been involved in AMS education and training across the world. He's a Fellow of Royal Pharmaceutical Society and has won the GHP/GSK/UKCPA Clinical Leadership Award, the UKCPA Lifetime Achievement Award and awarded the Officer of the British Empire (OBE) medal for his services to healthcare. He is a spokesman for the Royal Pharmaceutical Society on Antimicrobials, and for the Antibiotic-Action and British Society of Antimicrobial Chemotherapy charities.

Dr. Henry Skinner, CEO of the AMR Action Fund, joins Dani Peters, CAIC Senior Advisor, for World Antimicrobial Awareness Week to discuss the status of the global campaign to combat antimicrobial resistance in this 8th episode of the AMR Action Podcast. Dr. Skinner shares his perspective on the challenges with the broken market, and the barriers that need to be overcome in order to expedite innovation for new antimicrobials. He also discusses incentive models for policy makers and why more robust investments are needed from the private sector. Finally, he shares his optimism stemming from new technologies that are being tested and supported through the AMR Action Fund.

In 2019, the World Health Organisation listed antimicrobial resistance as one of the top 10 threats to global health. In 2020 and 2021, they repeated the call. Have we made any progress in addressing antimicrobial resistance, and does the pandemic offer any lessons to be learnt? We commemorate World Antimicrobial Awareness Week (observed from 18-24 November every year) in this conversation with Assoc Prof Dr Sasheela Ponnampalavanar, Consultant Infectious Disease Physician, University Malaya Medical Centre. Image credit: Shutterstock

This episode, in the middle of World Antimicrobial Awareness Week, we talk to Dr Leanne Teoh, a dual qualified practising dentist and pharmacist about antimicrobial resistance and prescribing. We ask Leanne: How and why she moved from pharmacy to dentistry The parallels between practising as a pharmacist and a dentist Working as a dental researcher (including a current research project on antibiotic prescribing) The importance of antimicrobial stewardship Antibiotic prescribing in dentistry The impact of COVID-19 on dental prescribing The three Ds – diagnosis, dental treatment and drugs You can find a link to the eviDent Foundation antibiotic prescribing research project survey here: https://www.evident.org.au/research/research-opportunities

This week on Cultivating Convos, we talk with ODA Animal Disease Diagnostic Laboratory experts about World Antimicrobial Awareness Week. Tune in to find out what it is and why it's important.

The antimicrobial resistance, or AMR, organisms are developing, and our bid to counter that with new ways of controlling them, is like an arms race – one we stand a better chance of winning if we use the antimicrobials that are still effective, more carefully. This special episode of CORDIScovery, timed to coincide with the WHO's annual World Antimicrobial Awareness Week (https://www.who.int/campaigns/world-antimicrobial-awareness-week/2021), invites three guests to share the work they are doing to win the race between the resistance microbes develop, and the ways we have to control them. Fredrik Almqvist (https://www.umu.se/en/staff/fredrik-almqvist/), co-founder of QureTech Bio AB, explains the work the QTB4AMR project is doing to change the chemical relationship between an antibiotic and its target bacteria. The weird and wonderful world of soil microbes and the ways in which they communicate could give rise to a new generation of biopesticides. Ana Bejarano (https://www.researchgate.net/profile/Ana-Bejarano-4) explains how her RhizoTalk project will help. How did farming become so systemically dependent on antibiotics and is it too late to turn that around? Nicolas Fortané(https://ritme.hypotheses.org/nicolas-fortane), who coordinates the ROADMAP project, shares his findings.

Most Australians will use antibiotics in our lifetimes but there is a lot we don't understand about how they work. In Episode 1 of our series we find out how most of us use antibiotics, what we know about them and what we get wrong. We hear stories about some of the most common uses of antibiotics, the uncertainty about when we need them and the fear that drives us to seek them when we may not, particularly for our children. We learn that antimicrobial resistance is a more complex issue than we can imagine – and why we're making this podcast.Here is a link to Davina's 2020 study:Role crisis, risk and trust in Australian general public narratives about antibiotic use and antimicrobial resistanceThere is some great information on antimicrobial resistance (AMR) from the Australian government here:https://www.amr.gov.auAnd from the World Health Organisation (WHO):https://www.who.int/health-topics/antimicrobial-resistanceFor more info on World Antimicrobial Awareness Week 2021 (18-24 November) head here:https://www.who.int/campaigns/world-antimicrobial-awareness-week/2021Host and producer: Dr Britta Jorgensen. Producers: Sarah Mashman and Silvi Vann-Wall. Executive Producer: Professor Mia Lindgren.

The world is now facing another looming health crisis - antimicrobial resistance (AMR) or "superbugs". The World Health Organisation has warned that we are headed towards a post-antibiotic era, in which common infections could become life-threatening.But the story of superbugs isn't as straightforward or as scary as it first sounds. In this new podcast, launched during World Antimicrobial Awareness Week 2021, you'll hear about the most common sources of resistant infections in Australia and the world. You'll hear stories from the people with firsthand experience of those infections, the doctors who treat them and the scientists researching them. We'll be taking you inside hospitals, pharmacies, vet clinics, planes, gardens, farms and waterways. We'll take you into the past and speculate on the future because, as you'll come to find out, antimicrobial resistance is present in almost every aspect of our lives. And the task of improving awareness and understanding of superbugs is a tough one.The podcast series is produced by a team of researchers and podcast producers, supported by funding and resources from the Australian Research Council and Swinburne University of Technology. The podcast series is one of the research outcomes from the project “Promoting Australian general public awareness and action on antimicrobial resistance” (ARCDP170100937), led by Associate Professor Mark Davis, conducted by social science and media researchers from Monash University, Swinburne University of Technology, University of Gothenburg and University of Strathclyde. Host and producer: Dr Britta Jorgensen. Producers: Sarah Mashman and Silvi Vann-Wall. Executive Producer: Professor Mia Lindgren.

World Antimicrobial Awareness Week (WAAW) (18-24th of November) aims to increase awareness of global antimicrobial resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of drug-resistant infections. In this episode Dr Bahijja Raimi-Abraham discusses antimicrobial awareness, antimicrobial resistance, microbial diagnostics and infection with Dr Tina Joshi (bio. available https://mondayscience.wixsite.com/podcast), Lecturer in Molecular Microbiology at the University of Plymouth. Episode image credit: https://unsplash.com/ Additional Information Publication mentioned with Scanning Electron Microscopy (SEM) image of Clostridium difficile spores survive on hospital gown fibres after disinfection. Biocide Resistance and Transmission of Clostridium difficile Spores Spiked onto Clinical Surfaces from an American Health Care Facility - 10.1128/AEM.01090-19 Dr Tina Joshi was involved in the "The End of Medicine" documentary due to be released in 2021 COVID mink analysis shows mutations are not dangerous — yet, Nature News King's College London Fight the Fakes - https://kclfightthefakes.wixsite.com/kingsftf Episode 2 (recap) Episode summary available MondayScience.Medium.com Let us know what you thought of the episode. Subscribe, follow, comment and get in touch! Submit your questions or send your voice note questions (up to 30 seconds) via www.mondaysciencepodcast.com e. MondayScience2020@gmail.com --- Send in a voice message: https://anchor.fm/mondayscience/message

World Antimicrobial Awareness Week (WAAW) (18-24th of November) aims to increase awareness of global antimicrobial resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of drug-resistant infections. In this episode Dr Bahijja Raimi-Abraham discusses antimicrobial awareness, antimicrobial resistance, microbial diagnostics and infection with Dr Tina Joshi (bio. available https://mondayscience.wixsite.com/podcast), Lecturer in Molecular Microbiology at the University of Plymouth. Episode image credit: https://unsplash.com/ Additional Information Publication mentioned with Scanning Electron Microscopy (SEM) image of Clostridium difficile spores survive on hospital gown fibres after disinfection. Biocide Resistance and Transmission of Clostridium difficile Spores Spiked onto Clinical Surfaces from an American Health Care Facility - 10.1128/AEM.01090-19 Dr Tina Joshi was involved in the "The End of Medicine" documentary due to be released in 2021 COVID mink analysis shows mutations are not dangerous — yet, Nature News King's College London Fight the Fakes - https://kclfightthefakes.wixsite.com/kingsftf Episode 2 (recap) Subscribe, follow, comment and get in touch! Submit your questions or send your voice note questions (up to 30 seconds) via https://mondayscience.wixsite.com/podcast e. MondayScience2020@gmail.com --- Send in a voice message: https://anchor.fm/mondayscience/message

Happy bonus episode listeners! To mark World Antimicrobial Awareness Week, the MTPConnect podcast team caught up with OUTBREAK Managing Director & Co-founder Associate Professor Branwen Morgan from the University of Technology Sydney and Distinguished Professor Antoine van Oijen, who is OUTBREAK's Deputy Managing Director and Director of Health Programs from the University of Wollongong, to talk about their new economic report on the impact of antimicrobial resistance in Australia released this week which shines a light on the multi-million dollar cost of drug-resistant infections and connects the overuse and misuse of antibiotics to the health and economic impact of a single disease. OUTBREAK is a national consortium whose analysis used big data and Artificial Intelligence to highlight how urinary tract infections (UTIs) are becoming more persistent and harder to treat, resulting in more people being admitted to hospital where they require longer stays and more costly medicines. Each year UTIs alone lead to 2.5 million GP appointments, 100K emergency visits and 75K hospital stays!. OUTBREAK is a member of MTPConnect's AAMRNet, Australia's first Antimicrobial Resistance Network launched in October 2020. The report is available to download at OUTBREAK Project's website: https://outbreakproject.com.au/antimicrobial-resistance-publications/utis-economic-report/. For more information on AMR, follow Twitter for updates at @AAMRNet_ and @OneHealthAU.

Welcome to our special contribution for World Antimicrobial Awareness Week 2020! In this episode we focus on the aspect of human behaviour in the AMR context. Why is it important? How can we motivate people to change the way the relate to antibiotics? What role do we all play in this? This are the very question that the Uppsala Health Summit will focus on next spring, and the questions that we bring to you today. For this episode, we have interviewed Dr. Ulf Magnusson, veterinarian and chair of the summit, and Dr. Birgitta Lytsy, an expert on infection prevention and control at the Uppsala Hospital. Listen to their experiences working to change behaviours and find sustainable solutions to curb the AMR crisis. Check relevant links and material at www.uac.uu.se/the-amr-studio/episodex6/. Follow our updates on twitter on www.twitter.com/uac_uu with #theAMRstudio hashtag! Theme music by Henrik Niss: www.tinyurl.com/henriknissspotify.